Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry
- Resource Type
- Source
- Leukemia & Lymphoma. 64:621-627
- Subject
Cancer Research Oncology Hematology - Language
- ISSN
- 1029-2403
1042-8194